|
Vitamins Prevent Baby's Cancer
Background: Neuroblastoma is a common type of solid cancer that
strikes infants and children. It arises in the adrenal gland and nervous
tissue related to the adrenal.
Summary: "In the largest epidemiologic study of neuroblastoma ever
conducted in North America, we found a 30% to 40% reduction in the risk of
this childhood cancer...due to the maternal use of multivitamins during
pregnancy." ( lead author Dr. Andrew F. Olshan of the University of North
Carolina).
Comment: This research provides additional support for the
recommendation that vitamin use before and during pregnancy is beneficial to
the health of the baby.
For more, please visit the following MedicineNet.com areas:
Barbara K. Hecht, Ph.D.
Medical Editor, MedicineNet.com
Maternal vitamin use significantly reduces neuroblastoma risk
Last Updated: 2002-08-27 8:31:06 -0400
By Steven Reinberg
NEW YORK (Reuters Health) - Women who take multivitamins before or during
pregnancy significantly reduce the risk of their offspring developing
neuroblastoma, researchers report in the September issue of Epidemiology.
"In the largest epidemiologic study of neuroblastoma ever conducted in
North
America, we found a 30% to 40% reduction in the risk of this childhood
cancer...due to the maternal use of multivitamins during pregnancy," lead
author Dr. Andrew F. Olshan told Reuters Health.
Dr. Olshan from the University of North Carolina, Chapel Hill, and
colleagues collected data on children diagnosed with neuroblastoma from May
1, 1992 to April 30, 1994 from 139 member hospitals of either of two US and
Canadian pediatric collaborative trials groups, Children's Oncology Group
and Pediatric Oncology Group. They also collected data on a matched control
group.
The researchers collected data on vitamin use before and during pregnancy
among mothers of 538 cases and of 504 controls.
Women who used a vitamin and mineral supplement in the month before
becoming pregnant or in any trimester reduced the risk for neuroblastoma by
30% to 40%, Dr. Olshan's team found. The team was not able to tell which
particular vitamins or minerals had this effect, they add.
Taking into account age when neuroblastoma was diagnosed or MYCN oncogene
amplification status did not substantially change the finding, the
investigators note.
"The finding should not be interpreted as causal, but as suggestive of an
association," Dr. Olshan said. "The specific vitamin(s) potentially
responsible for the reduction in risk are uncertain. Additional study,
especially laboratory work, is needed to evaluate the potential for specific
vitamins or combinations to modify the initiation and/or progression of
neuroblastoma," he added.
MedicineNet Home |
Condition Sites |
Help |
Privacy |
About Us |
My Account
|
Premium Services |
Advertise with Us |
Content Licensing
VeriSign |
TRUSTe
We subscribe to the HONcode principles.Verify here.
|